Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)

被引:9
|
作者
Klaas, Lioba [1 ]
Vier, Juliane [1 ]
Gentle, Ian E. [1 ]
Hacker, Georg [1 ]
Kirschnek, Susanne [1 ]
机构
[1] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, Fac Med, Freiburg, Germany
关键词
PROGRAMMED NECROSIS; DENDRITIC CELLS; NECROPTOSIS; PHOSPHORYLATION; APOPTOSIS; CASPASES; PROTEIN; DEGRADATION; ACTIVATION; INDUCTION;
D O I
10.1038/s41419-021-04286-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Regulated cell death frequently occurs upon infection by intracellular pathogens, and extent and regulation is often cell-type-specific. We aimed to identify the cell death-signaling pathways triggered in macrophages by infection with modified vaccinia virus Ankara (MVA), an attenuated strain of vaccinia virus used in vaccination. While most target cells seem to be protected by antiapoptotic proteins encoded in the MVA genome, macrophages die when infected with MVA. We targeted key signaling components of specific cell death-pathways and pattern recognition-pathways using genome editing and small molecule inhibitors in an in vitro murine macrophage differentiation model. Upon infection with MVA, we observed activation of mitochondrial and death-receptor-induced apoptosis-pathways as well as the necroptosis-pathway. Inhibition of individual pathways had a little protective effect but led to compensatory death through the other pathways. In the absence of mitochondrial apoptosis, autocrine/paracrine TNF-mediated apoptosis and, in the absence of caspase-activity, necroptosis occurred. TNF-induction depended on the signaling molecule STING, and MAVS and ZBP1 contributed to MVA-induced apoptosis. The mode of cell death had a substantial impact on the cytokine response of infected cells, indicating that the immunogenicity of a virus may depend not only on its PAMPs but also on its ability to modulate individual modalities of cell death. These findings provide insights into the diversity of cell death-pathways that an infection can trigger in professional immune cells and advance our understanding of the intracellular mechanisms that govern the immune response to a virus.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model
    Carroll, MW
    Overwijk, WW
    Chamberlain, RS
    Rosenberg, SA
    Moss, B
    Restifo, NP
    VACCINE, 1997, 15 (04) : 387 - 394
  • [22] Quantitative proteomics defines mechanisms of antiviral defence and cell death during modified vaccinia Ankara infection
    Jonas D. Albarnaz
    Joanne Kite
    Marisa Oliveira
    Hanqi Li
    Ying Di
    Maria H. Christensen
    Joao A. Paulo
    Robin Antrobus
    Steven P. Gygi
    Florian I. Schmidt
    Edward L. Huttlin
    Geoffrey L. Smith
    Michael P. Weekes
    Nature Communications, 14
  • [23] Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccines Efficiently Protect Cockatiels Against Parrot Bornavirus Infection and Proventricular Dilatation Disease
    Rall, Isabell
    Amann, Ralf
    Malberg, Sara
    Herden, Christiane
    Rubbenstroth, Dennis
    VIRUSES-BASEL, 2019, 11 (12):
  • [24] Purification of modified vaccinia virus Ankara from suspension cell culture
    Ingo Jordan
    Diana Weimer
    Stefan Iarusso
    Holger Bernhardt
    Verena Lohr
    Volker Sandig
    BMC Proceedings, 9 (Suppl 9)
  • [25] Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine
    Zhou, Ya Bin
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12):
  • [26] Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells
    Nemecková, S
    Hainz, P
    Otáhal, P
    Gabriel, P
    Sroller, V
    Kutinová, L
    ACTA VIROLOGICA, 2001, 45 (04) : 243 - 247
  • [27] Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
    Cottingham, Matthew G.
    Andersen, Rikke F.
    Spencer, Alexandra J.
    Saurya, Saroj
    Furze, Julie
    Hill, Adrian V. S.
    Gilbert, Sarah C.
    PLOS ONE, 2008, 3 (02):
  • [28] Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells
    Erez, Noam
    Wyatt, Linda S.
    Americo, Jeffrey L.
    Xiao, Wei
    Moss, Bernard
    JOURNAL OF VIROLOGY, 2021, 95 (19)
  • [29] Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
    Altenburg, Arwen F.
    Kreijtz, Joost H. C. M.
    de Vries, Rory D.
    Song, Fei
    Fux, Robert
    Rimmelzwaan, Guus F.
    Sutter, Gerd
    Volz, Asisa
    VIRUSES-BASEL, 2014, 6 (07): : 2735 - 2761
  • [30] Production of prostaglandin E2 in response to infection with modified vaccinia Ankara virus
    Pollara, Justin J.
    Spesock, April H.
    Pickup, David J.
    Laster, Scott M.
    Petty, Ian T. D.
    VIROLOGY, 2012, 428 (02) : 146 - 155